Rapid oral transmucosal delivery of zaleplon-lavender oil utilizing self-nanoemulsifying lyophilized tablets technology: development, optimization and pharmacokinetic evaluation.

Drug Deliv · 2022 · PMC9429977 · PMID 36036168

Europe PMC DOI

hedged sentence

0.0001

closest p · 0.0× alpha

0.0001

boldest claim

The sentences

highly significantp-value < .0001actually significant

The difference in the release time of 50% of loaded ZP dose between the prepared tablets and commercial ones was found to be highly significant (p-value < .0001). 3.9.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.